{
  "url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2004/article-3",
  "json_url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2004/article-3.json",
  "legislation": "uksi/2004/2",
  "legislation_title": "The Prescription Only Medicines (Human Use) Amendment Order 2004",
  "legislation_url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2004",
  "path": "article/3",
  "kind": "article",
  "number": "3",
  "heading": "Amendment of Schedule 3A to the principal Order",
  "text": "In the table in Schedule 3A to the principal Order (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration)—\n(a) for the entry for “Erythromycin”, in column 2, after “External Use” insert “or oral”;\n(b) for the entry “Fusidic acid”, in column 2 for “Opthalmic Use” substitute “External Use”;\n(c) for the entry “Hycosine butylbromide”, in column 2, after “parenteral” insert “or transdermal”;\n(d) for the entry “Hycosine hydrobromide”, in column 2, for “Oral, parenteral or transdermal administration in palliative care” substitute “Oral or parenteral administration in palliative care”;\n(e) for the entry “Metronidazole”, in column 2 for “External use or oral” substitute “External use, oral or rectal”;\n(f) for the entry “Prednisolone sodium phosphate”, in column 2, after “Aural” insert “or oral”;\n(g) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 below, and in column 2 insert, against those entries, the corresponding entries in column 2 below—\nColumn 1\nColumn 2\nAmitriptyline hydrochloride\nOral\nAzithromycin dihydrate\nOral\nCarbamazepine\nOral or rectal\nClavulanic acid\nOral\nConjugated oestrogens (equine)\nExternal use\nDiclofenac potassium\nOral\nDiclofenac sodium\nOral or rectal\nErythromycin ethyl succinate\nOral\nErythromycin stearate\nOral\nEstradiol\nExternal use\nEstriol\nExternal use\nEtonogestrel\nImplant\nFlumazenil\nParenteral\nGabapentin\nOral\nGlucagon hydrochloride\nParenteral\nGlucose\nParenteral\nImipramine hydrochloride\nOral\nLignocaine hydrochloride\nExternal use or parenteral\nLymecycline\nOral\nNortriptyline hydrochloride\nOral\nPrednisolone\nOral\nSalbutamol sulphate\nInhalation\nSodium fusidate\nExternal use\nTerbutaline sulphate\nInhalation",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Schedule 3A was inserted by SI 2002/549, and amended by SI 2003/696 and 2915."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2004/2/article/3",
    "retrieved_at": "2026-10-29T05:36:06.248755+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}